DOCSLIB.ORG

Roles of Oral Bacteria in Cardiovascular Diseases—From

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Roles of Oral Bacteria in Cardiovascular Diseases—From J Pharmacol Sci 113, 000 – 000 (2010) Journal of Pharmacological Sciences ©2010 The Japanese Pharmacological Society Forum Minireview Roles of Oral Bacteria in Cardiovascular Diseases — From Molecular Mechanisms to Clinical Cases: Implication of Periodontal Diseases in Development of Systemic Diseases Hiroaki Inaba1 and Atsuo Amano1,* 1Department of Oral Frontier Biology, Graduate School of Dentistry, Osaka University, Suita 565-0871, Japan Received November 16, 2009; Accepted December 21, 2009 Abstract. Periodontal diseases, some of the most common infectious diseases seen in humans, are characterized by gingival inflammation, as well as loss of connective tissue and bone from around the roots of the teeth, which leads to eventual tooth exfoliation. In the past decade, the as- sociation of periodontal diseases with the development of systemic diseases has received increas- ing attention. Although a number of studies have presented evidence of close relationships between periodontal and systemic diseases, the majority of findings are limited to epidemiological studies, while the etiological details remain unclear. Nevertheless, a variety of recent hypothesis driven investigations have compiled various results showing that periodontal infection and subsequent direct oral-hematogenous spread of bacteria are implicated inPROOF the development of various systemic diseases. Herein, we present current understanding in regard to the relationship between periodon- tal and systemic diseases, including cardiovascular diseases, preterm delivery of low birth weight, diabetes mellitus, respiratory diseases, and osteoporosis. Keywords: periodontal disease, diabetes mellitus, cardiovascular disease, preterm delivery, Porphyromonas gingivalis, oral bacteria 1. Introduction detected in heart valve lesions and atheromatous plaque (5, 6), amniotic fluid of pregnant women with threatened Epidemiological and interventional studies of humans premature labor (11), and placentas from cases of preterm have revealed close associations between periodontal delivery (12, 13). Although a definitive role for P. gingi- diseases and systemic diseases, such as cardiovascular valis in systemic diseases has yet to be established, the disease (CVD)UNCORRECTED (1 – 8), preterm delivery of low birth involvement of the bacterium in these disorders has been weight (PTLBW) (9 – 14), diabetes mellitus (15 – 18), strongly suggested. respiratory infection (19), and osteoporosis (20, 21). This review provides an overview of the relationship From those results, it is not an exaggeration to state that between chronic periodontitis and systemic diseases, in- periodontal infection represents a significant risk factor cluding CVD, PTLBW, diabetes mellitus, respiratory for various systemic diseases. Porphyromonas gingivalis diseases, and osteoporosis. has been reported to be involved in the development of systemic diseases due to systemic inflammation with 2. Periodontitis increased circulating cytokines and mediators, direct in- fection, and cross-reactivity/molecular mimicry between Periodontal (gum) diseases, including gingivitis and bacterial antigens and self-antigens (22). Furthermore, chronic periodontitis, are serious infections that, left un- periodontal pathogens including P. gingivalis have been treated, can lead to tooth loss. Periodontal disease has been proposed to affect at least one tooth in 80% of adults *Corresponding author. [email protected] worldwide (23), with the main cause shown to be bacte- Published online in J-STAGE rial plaque (also called biofilm), which is a sticky, color- doi: 10.1254/jphs.09R23FM less film that constantly forms on teeth (Fig. 1). Gingivitis 1 2 H Inaba and A Amano is manifested by red, swollen gums and bleeding that appear to be compromised (30). It should be noted that may occur with tooth brushing and can advance to peri- traditional anti-infective periodontal therapies, such as odontitis when untreated. Over time, plaque biofilm can scaling and root planing, with or without adjunctive an- spread and grow below the gum line (subgingival area), tibiotics, not only improve the clinical symptoms of and toxins produced by the bacteria in plaque biofilm periodontitis, but also improve local antioxidant status irritate the gums. Those toxins stimulate a chronic in- (30) and systemic vascular endothelial dysfunction (31) flammatory response in which the body, in essence, turns and reduce PMNL hyper-reactivity (28). on itself, and the tissues and bone that support the teeth are broken down and destroyed. In this process, gums 4. CVD separate from the teeth, forming periodontal pockets (spaces between teeth and gums) that become infected. CVD refers to a group of disorders of the heart and As the disease progresses, the pockets deepen and more vasculature and includes high blood pressure, coronary gum tissue and bone are destroyed. Often, this destruc- heart disease (CHD), congestive heart failure, stroke, and tive process has very mild symptoms, though teeth can myocardial infarction (32). These diseases account for eventually become loose and may have to be removed. In approximately 17 million deaths per annum and 40% of developed countries, chronic periodontitis has been esti- all deaths worldwide, with atherosclerosis the underlying mated to effect up to 22% of the adult population, with etiology in the vast majority of cases (32). In addition to moderate and severe forms affecting 13% (23). Although traditional exacerbation factors, such as smoking, hyper- the etiology of chronic periodontitis is multifactorial, cholesterolemia, hypertension, and diabetes mellitus (32, evidence exists indicating that specific Gram-negative 33), periodontitis has been shown to be linked to the bacteria in subgingival plaque biofilm play an important development of atherosclerosis (23). Recently, an Edi- role in progression of the disease (23). The oral cavity tors’ consensus regarding “Periodontitis and Atheroscle- supports more than 700 different bacterial species and rotic CVD” presented in the American Journal of Cardi- the periodontal pocket area harbors more than 400 spe- ology and Journal of Periodontology noted a significant cies. Among the various subgingival plaque bacterial relationship betweenPROOF periodontitis and atherosclerotic species, substantial evidence indicates roles for 3 species, CVD (34, 35). P. gingivalis, Treponema denticola, and Tannerella for- The relationship between CHD and periodontitis was sythia, in initiation and progression of the disease, with first reported at the end of the 1980s (36). Periodontal P. gingivalis implicated as a major etiological agent health is a significant predictor of coronary atheromatosis (24). along with the following parameters: age, sex, socioeco- nomic status, smoking, hypertension, number of previous 3. Oral-hematogenous spread of bacteria myocardial infarctions, diabetes mellitus, body mass in- dex, and serum lipid levels (1). Since a significant epide- In the oral cavity, the innate host defense system is miological relationship was known at that time, etiologi- thought to act toward limiting the spread of oral bacteria cal investigations were not performed to determine by maintaining intact gingival epithelium, an innate whether oral infection is a risk factor for CVD or if oral physical barrier. The epithelium is also important in or- bacteria directly affect cardiovascular condition. How- chestrating hostUNCORRECTED inflammatory responses (25). However, ever, in the recent decade, the epidemiological causal as the disease progresses, the epithelium becomes ulcer- association between periodontal disease and CHD has ated to expose the underlying connective tissues and been reconsidered (2), with meta-analysis revealing that blood capillaries to plaque biofilm. The exposed ulcer- periodontal disease is likely associated with the risk of ative area, which has an area ranging from 8 – 20 cm2 in future CHD, which is increased in individuals older than an oral cavity with medium periodontitis (26, 27), facili- 65 years (3). tates direct entry of biofilm organisms to the circulation Bacterial DNAs of periodontal pathogens, such as during eating and tooth brushing. This oral-hematogenous P. gingivalis, T. forsythia, T. denticola, Aggregatibacter spread of bacteria is thought to be a main cause of peri- actinomycetemcomitans, and Campylobacter rectus, odontitis-related systemic diseases (Fig. 2). Furthermore, have been detected in stenotic coronary artery plaque peripheral polymorphonuclear leukocytes (PMNLs) from samples (4) and aneurysmal wall and aneurysmal throm- patients with periodontitis have been reported to be hyper- bus tissues (5). In that latter study, patients with Buerger reactive as compared to controls with respect to the re- disease had significantly higher serum IgG titers against lease of reactive oxygen species (28) and PMNL-specific T. denticola, P. gingivalis, and A. actinomycetemcomi- proteases (28). In addition, the levels of inflammatory tans, while DNAs of those bacteria have been detected in markers are also elevated (29) and antioxidant defenses occluded artery tissues (6). In addition, the occurrence of Periodontal Diseases and Systemic Diseases 3 P. gingivalis in stenotic coronary artery plaque specimens from patients with severe periodontitis was 5-fold greater than that in those from patients with medium periodonti- tis (4). However, those results are not conclusive to di- rectly imply that periodontal pathogens in lesions are directly implicated
Load more

Recommended publications
  • Comparative Genome Analysis of 19 Ureaplasma Urealyticum and Ureaplasma Parvum Strains
    Paralanov et al. BMC Microbiology 2012, 12:88 http://www.biomedcentral.com/1471-2180/12/88 RESEARCH ARTICLE Open Access Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains Vanya Paralanov1, Jin Lu2, Lynn B Duffy2, Donna M Crabb2, Susmita Shrivastava1, Barbara A Methé1, Jason Inman1, Shibu Yooseph1, Li Xiao2, Gail H Cassell2, Ken B Waites2 and John I Glass1* Abstract Background: Ureaplasma urealyticum (UUR) and Ureaplasma parvum (UPA) are sexually transmitted bacteria among humans implicated in a variety of disease states including but not limited to: nongonococcal urethritis, infertility, adverse pregnancy outcomes, chorioamnionitis, and bronchopulmonary dysplasia in neonates. There are 10 distinct serotypes of UUR and 4 of UPA. Efforts to determine whether difference in pathogenic potential exists at the ureaplasma serovar level have been hampered by limitations of antibody-based typing methods, multiple cross-reactions and poor discriminating capacity in clinical samples containing two or more serovars. Results: We determined the genome sequences of the American Type Culture Collection (ATCC) type strains of all UUR and UPA serovars as well as four clinical isolates of UUR for which we were not able to determine serovar designation. UPA serovars had 0.75−0.78 Mbp genomes and UUR serovars were 0.84−0.95 Mbp. The original classification of ureaplasma isolates into distinct serovars was largely based on differences in the major ureaplasma surface antigen called the multiple banded antigen (MBA) and reactions of human and animal sera to the organisms. Whole genome analysis of the 14 serovars and the 4 clinical isolates showed the mba gene was part of a large superfamily, which is a phase variable gene system, and that some serovars have identical sets of mba genes.
    [Show full text]
  • Fis-His-2020-Abstract-Supplement-Free-Paper.Pdf
    Abstract supplement (free paper abstracts) FIS/HIS International 2020 cannot be held responsible for errors or inconsistencies contained within the abstract supplement. Only major formatting alterations have been made and abstract content remains consistent with what was entered at time of submission by the author/s. How to search this document Laptop, PC or similar: ‘Ctrl’ + ‘F’ or ‘Edit’ then ‘Find’ Smart device: Open this PDF in either the 'iBooks' app (Apple) or 'My Files' app (Android). Both are built in apps and have a magnifying glass search icon. Contents A quick reference guide by topic, paper number and presentation type can be found at the end of the document or click here. (Click paper title to take you straight there) Free paper oral presentations 11: Investigations, actions and learning from an outbreak of SARS-CoV-2 infection among health care workers in the United Kingdom ........................................................................................................................ 13 12: Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care ...................... 14 20: Impact of antibiotic timing on mortality from Gram negative Bacteraemia in an English District General Hospital: the importance of getting it right every time .................................................................................... 15 35: Case report: A fall in the forest ................................................................................................................... 16 65: Not
    [Show full text]
  • CASEE-2017 Session1b -Eva-Tvrda
    A The 8th International CASEE Conference Warsaw University of Life Sciences – SGGW May 14 - 16, 2017 . Decreased sperm quality visible in routine semen analysis: . loss of sperm motility . morphological alterations . acrosome dysfunction . disruption of membrane integrity . oxidative stress . Most data connected to bacterial contamination of ejaculates: well-known causative agents of urogenital tract infections . Escherichia coli, Staphylococcus aureus, Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis . Ejaculates collected for reproductive technologies - certain contamination: . semen collection is not an entirely serile process . factors for semen contamination: artifical vaginas, environmental conditions, human factors . Current interest shifts to other bacteria, responsible for the colonization and contamination of the male urogenital tract, rather than infection . Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic bacteria . Lactic acid bacteria (LAB) that produce bacteriocins . Origins: environmental, animal and human sources . E. faecalis: . most common in the gastrointestinal tract, and may be found in human and animal faeces . associated with clinical urinary tract infections, hepatobiliary sepsis, endocarditis, surgical wound infection, bacteraemia and neonatal sepsis . able to survive a range of adverse environments allowing multiple routes of cross- contamination . resistant to a broad range of antibiotics including ampicillin, ciprofloxacin and imipenem ANTIBIOTICS NATURALLY OCCURING
    [Show full text]
  • GBS 10 Strep11 Other 60 Vaginal Swabs! Real-Time LAMP!
    • Specificity studies were performed using a panel of 10 Group B Streptococcus agalactiae strains, 11 of the most commonly occurring Streptococcus genus strains and 60 other organisms commonly found in the human genital tract. • One hundred and twenty four (124) vaginal swabs sampled from pregnant women were tested with the real-time LAMP assay and compared to a real- time PCR assay (5). Neonatal infections are most commonly caused by Group B Streptococcus GBS 10 (Streptococcus agalactiae) (1). These infections can be classified as either early on-set • Of the 124 vaginal swabs, 85 tested positive for Group B Streptococcus and & or late-onset disease. Early onset infection (EOI) occurs during the first week of life 39 tested negative. with late onset infection (LOI) occurring between one week and three months. It is Strep11 thought that early onset disease develops in the foetus after aspiration of infected • Comparable results were achieved by both the real-time PCR and real –time amniotic fluid (2). Late onset infection is less well understood, and while passage LAMP assays. Results are listed in Table 4. Also shown in the table are through the birth canal is an obvious route of infection, it is also thought that community previously obtained microbiological culture data for the isolation and sources are involved (2). Other identification of GBS. 60 One approach used to identify potential for infection is a screening of pregnant women, where prophylaxis is offered to those identified as carriers (3). This approach is also • Figure 1: Breakdown of specificity panels investigated during the development of the Table 2: Results of GBS testing of vaginal swabs.
    [Show full text]
  • Research Article Rapid PCR Detection of Mycoplasma Hominis, Ureaplasma Urealyticum,Andureaplasma Parvum
    Hindawi Publishing Corporation International Journal of Bacteriology Volume 2013, Article ID 168742, 7 pages http://dx.doi.org/10.1155/2013/168742 Research Article Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum,andUreaplasma parvum Scott A. Cunningham,1 Jayawant N. Mandrekar,2 Jon E. Rosenblatt,1 and Robin Patel1,3 1 Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA 2 Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN 55905, USA 3 Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA Correspondence should be addressed to Robin Patel; [email protected] Received 5 November 2012; Accepted 30 January 2013 Academic Editor: Sam R. Telford Copyright © 2013 Scott A. Cunningham et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. We compared laboratory developed real-time PCR assays for detection of Mycoplasma hominis and for detection and differentiation of Ureaplasma urealyticum and parvum to culture using genitourinary specimens submitted for M. hominis and Ureaplasma culture. Methods. 283 genitourinary specimens received in the clinical bacteriology laboratory for M. hominis and Ureaplasma species culture were evaluated. Nucleic acids were extracted using the Total Nucleic Acid Kit on the MagNA Pure 2.0. 5 L of the extracts were combined with 15 L of each of the two master mixes. Assays were performed on the LightCycler 480 II system. Culture was performed using routine methods.
    [Show full text]
  • Prevalence of Ureaplasma Urealyticum, Mycoplasma Hominis and Chlamydia Trachomatis in Patients with Uncomplicated Recurrent Urin
    Nephrology and Renal Diseases Research Article ISSN: 2399-908X Prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with uncomplicated recurrent urinary tract infections Jadranka Vlasic-Matas1*, Hrvoje Raos2, Marijana Vuckovic2, Stjepan Radic2 and Vesna Capkun3 1Polyclinic Nephrology Department, Split, Croatia 2School of Medicine, University of Split, Split, Croatia 3Department of Nuclear Medicine, Split University Hospital Center, Split, Croatia Abstract Aim: To assess the prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with chronic urinary tract infections (UTIs) and its correlation with leukocyturia and symptoms. Methods: The study included 220 patients (130 women and 90 men) presenting with chronic voiding symptoms and sterile leukocyturia. Urine, urethral swabs and cervical swabs (for women patients) were taken to determine the presence of these pathogens. Patients were treated by tetracycline and followed up three and six months after initial therapy. Results: In 186 (85%) out of 220 patients, U. urealyticum was found, while C. trachomatis was present in 34 patients (15%). In majority of female patients (112 out of 130; 86%) U. urealyticum was found. In addition to ureaplasma, in eight patients M. hominis was found. C. trachomatis was identified in 18 female patients (14%). In 74 out of 90 (82%) male patients U. urealyticum was detected while in six of them M. hominis was also found. C. trachomatis was identified in 16 male patients (18%). U. urealyticum was significantly related to leukocyturia, as opposed to C. trachomatis (p<0,001). Women had more frequent symptomatology (p = 0,015) and higer leukocyturia (p<0.001). Conclusion: Leukocyturia is more common find in U.
    [Show full text]
  • Anterior Nares Acidovorax Ebreus 100% Acidovorax Sp
    Anterior Nares Acidovorax ebreus 100% Acidovorax sp. Acinetobacter johnsonii Acinetobacter lwoffii 10% Actinobacillus minor Actinomyces odontolyticus Actinomyces sp. 1% Actinomyces urogenitalis Aggregatibacter aphrophilus Alistipes putredinis 0.1% Anaerococcus hydrogenalis Anaerococcus lactolyticus 0.01% Anaerococcus prevotii Anaerococcus tetradius Anaerococcus vaginalis 0.001% Atopobium vaginae Bacteroides dorei Bacteroides intestinalis 0.0001% Bacteroides sp. Bacteroides stercoris Bacteroides vulgatus 0.00001% Campylobacter concisus Campylobacter gracilis Campylobacter hominis Campylobacter lari Campylobacter showae Candidate division Capnocytophaga gingivalis Capnocytophaga ochracea Capnocytophaga sputigena Cardiobacterium hominis Catonella morbi Citrobacter sp. Clostridium leptum Corynebacterium accolens Corynebacterium ammoniagenes Corynebacterium amycolatum Corynebacterium diphtheriae Corynebacterium efficiens Corynebacterium genitalium Corynebacterium glutamicum Corynebacterium jeikeium Corynebacterium kroppenstedtii Corynebacterium lipophiloflavum Corynebacterium matruchotii Corynebacterium pseudogenitalium Corynebacterium pseudotuberculosis Corynebacterium resistens Corynebacterium striatum Corynebacterium tuberculostearicum Corynebacterium urealyticum Delftia acidovorans Dialister invisus Eikenella corrodens Enhydrobacter aerosaccus Eubacterium rectale Finegoldia magna Fusobacterium nucleatum Fusobacterium periodonticum Fusobacterium sp. Gardnerella vaginalis Gemella haemolysans Granulicatella adiacens Granulicatella elegans Haemophilus
    [Show full text]
  • Reactive Arthritis Or Chronic Infectious Arthritis? J Sibilia, F-X Limbach
    580 REVIEW Ann Rheum Dis: first published as 10.1136/ard.61.7.580 on 1 July 2002. Downloaded from Reactive arthritis or chronic infectious arthritis? J Sibilia, F-X Limbach ............................................................................................................................. Ann Rheum Dis 2002;61:580–587 Microbes reach the synovial cavity either directly during hence active multiplication of the bacteria. bacteraemia or by transport within lymphoid cells or These findings thus suggest that microbes can survive in small numbers in the articular cavity monocytes. This may stimulate the immune system in certain forms of ReA (table 1). excessively, triggering arthritis. Some forms of ReA • The phenomenon has grown since 1995 with correspond to slow infectious arthritis due to the discovery of DNA of most other classical persistence of microbes and some to an infection arthritogenic agents in synovial samples from patients with ReA.18–21 One must nevertheless triggered arthritis linked to an extra-articular site of take a fairly critical point of view because infection. although the results are convincing for C .......................................................................... trachomatis, they are much less so for entero- bacteria. It is true that DNA of Yersinia, Shigella, or Campylobacter has been identified in some eactive arthritis (ReA) was first described in studies, but these are few and include very few 1916 during the first world war by Fiessinger patients.18 19 21 22 Thus, Ekman et al identified and Leroy in France and Reiter in Germany. R DNA of Salmonella in synovial samples,23 but It was, however, only in 1969 that a Scandinavian could not repeat their results. This might have team rationalised the concept of ReA by defining it as a transient non-purulent (reactive) arthritis been owing to technical artefacts, which lead appearing in the weeks following a digestive to false positives, or to a very small amount of infection.1 Actually, this notion of exclusively bacterial DNA in the synovium.
    [Show full text]
  • Are You Suprised ?
    DAMB 711 Microbiology Final Exam B 100 points December 16, 2009 Your name (Print Clearly): _____________________________________________ Exam # __________ Seat # ___________ CPA # ____________ I. Multiple Choice: Choose the ONE BEST answer. Mark the correct answer on Part 1 of the answer sheet. Use a #2 pencil. 1. Which of the following describes the infectious agent of a microorganism that causes atypical pneumoniae? A. fecal material from a patient harboring Salmonella typhi B. endospores of Clostridium botulinum C. Treponema pallidum in a chancre D. the reticulate body of Chlamydia trachomatis. E. the elementary body of Chlamydia pneumoniae 2. Many bacteria are intracellular parasites with specialized mechanisms for survival inside cells. One of the following is not a mechanism for survival in the cell. Which one? A. Shigella’s escape from the endosome. B. Mycobacterial prevention of phagosome and lysosome fusion. C. Salmonella’s transcription of an acid tolerance response gene. D. Aggregatibacter’s leukotoxin 3. Diabetic patients are predisposed to __________________ caused by___________________: A. athlete’s foot: Candida albicans B. typhus: Rickettsia typhi C. rhino-cerebral zygomycosis: Mucor species D. hypersensitivities: Aspergillus fumigatus E. lung infections: Coccidioides immitis 4. Chalmydia psittaci and Cryptococcus neoformans have the following in common: A. They are both molds. B. They are both yeasts. C. Their infectious agents are transmitted in avian feces. D. A, B and C are true E. B and C are true. 5. Members of the genus Mycoplasma are unique among bacteria because they: A. have a rudimentary life cycle. B. have a primary arthropod host that is both a vector and a reservoir.
    [Show full text]
  • Roles of the Vagina and the Vaginal Microbiota in Urinary Tract Infection: Evidence from Clinical Correlations and Experimental Models
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 1-1-2020 Roles of the vagina and the vaginal microbiota in urinary tract infection: Evidence from clinical correlations and experimental models Amanda L Lewis Nicole M Gilbert Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Urogenital infections and inflammations OPEN ACCESS Review Article Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models Abstract Mounting evidence indicates that the vagina can harbor uropathogenic Amanda L. Lewis1,2,3 bacteria. Here, we consider three roles played by the vagina and its Nicole M. Gilbert2,3,4 bacterial inhabitants in urinary tract infection (UTI) and urinary health. First, the vagina can serve as a reservoir for Escherichia coli, the most common cause of UTI, and other recognized uropathogens. Second, 1 Molecular Microbiology, several vaginal bacterial species are frequently detected upon urine Washington University School culture but are underappreciated as uropathogens, and other vaginal of Medicine in Saint Louis, species are likely under-reported because of their fastidious nature. United States Third, some vaginal bacteria that are not widely viewed as uropathogens 2 Obstetrics and Gynecology, can transit briefly in the urinary tract, cause injury or immunomodulation, Washington University School and shift the balance of host-pathogen interactions to influence the of Medicine in Saint Louis, outcomes of uropathogenesis. This chapter describes the current liter- United States ature in these three areas and summarizes the impact of the vaginal 3 Center for Women's microbiota on susceptibility to UTI and other urologic conditions.
    [Show full text]
  • Detection and Characterisation of Ureaplasma Spp in Men with and Without Urogenital Symptoms
    Detection and characterisation of Ureaplasma spp in men with and without urogenital symptoms NONTUTHUKO EXCELLENT MANINGI Detection and characterisation of Ureaplasma spp in men with and without urogenital symptoms by NONTUTHUKO EXCELLENT MANINGI Submitted in partial fulfilment of the requirements for the degree Magister Scientiae Department of Medical Microbiology Faculty of Health Sciences University of Pretoria Pretoria South Africa January 2012 The things that will destroy us are: politics without principle, pleasure without conscience, wealth without work, knowledge without character, business without morality, science without humanity, and worship without sacrifice. M ahatma G andhi Declaration I, Nontuthuko Excellent Maningi, hereby declare that the work on which this dissertation is based, is original and that neither the whole work nor any part of it has been, is being, or is to be submitted for another degree at this or any other university or tertiary education institution or examination body. ................................................................. Signature of candidate ............................................................... Date ACKNOWLEDGEMENTS First, I want to thank the Almighty, who made all things possible for me. To my family, especially my mother and my late father who never gave up on me, I wouldn’t have done it without their support and encouragement. I want to thank my supervisor Dr Kock for all the assistance, guidance and encouragement she has given me throughout my MSc. A special thanks to my co-supervisor Prof AA Hoosen, he was not only a supervisor but also a father to me, he has inspired me from the first day I met him. I also want to thank the Department of Medical Microbiology, Dr Adam and the NHLS (Tshwane Academic Division) for the opportunity to perform this research and use of their facilities.
    [Show full text]
  • HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do
    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use • See Full Prescribing Information for additional indication specific ® ® ACTICLATE and ACTICLATE CAP safely and effectively. See dosage information and important administration instructions for ® ® full prescribing information for ACTICLATE and ACTICLATE ACTICLATE and ACTICLATE CAP. (2.1, 2.4, 2.5) CAP. ---------------DOSAGE FORMS AND STRENGTHS----------­ • ® ACTICLATE Tablets: 75 mg and 150 mg (functionally scored) ACTICLATE (doxycycline hyclate) tablets, for oral use (3) ® ACTICLATE CAP (doxycycline hyclate) capsules, for oral use • ACTICLATE CAP Capsules: 75 mg (3) Initial U.S. Approval: 1967 ---------------------CONTRAINDICATIONS----------------------­ ACTICLATE and ACTICLATE CAP are contraindicated in persons ----------------------INDICATIONS AND USAGE----------------­ who have shown hypersensitivity to any of the tetracyclines. (4) ® ® ACTICLATE and ACTICLATE CAP are tetracycline class drugs -------------------WARNINGS AND PRECAUTIONS-----------­ indicated for: • The use of ACTICLATE and ACTICLATE CAP during tooth • Rickettsial infections (1.1) development (last half of pregnancy, infancy and childhood to the • Sexually transmitted infections (1.2) age of 8 years) may cause permanent discoloration of the teeth • Respiratory tract infections (1.3) (yellow-gray-brown) and enamel hypoplasia Advise the patient of • Specific bacterial infections (1.4) the potential risk to the fetus during pregnancy. (2.2, 5.1, 8.1, 8.4) • Ophthalmic infections (1.5) • The use of ACTICLATE and ACTICLATE CAP during the • Anthrax, including inhalational anthrax (post-exposure) (1.6) second and third-trimester of pregnancy, infancy and childhood • Alternative treatment for selected infections when penicillin is up to the age of 8 years may cause reversible inhibition of bone contraindicated (1.7) growth.
    [Show full text]